News tagged with philadelphia
A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug in a phase I clinical trial reported in the current edition of The New England Journal of Medicine.
Cancer Nov 28, 2012 | not rated yet | 0 |
Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with existing leukemia therapies.
Cancer Aug 13, 2012 | not rated yet | 0 |
Dr. Hilary Koprowski, the Polish-born researcher who developed the first successful oral vaccination for polio, died this week at his Philadelphia home. He was 96.
Medications Apr 14, 2013 | 4.7 / 5 (3) | 1
(HealthDay)—Many parents of children with advanced cancer have high to severe levels of psychological distress, a new study finds.
Pediatrics Apr 02, 2013 | 3 / 5 (2) | 1
(HealthDay)—Black children are less likely to be prescribed antibiotics and to be diagnosed with conditions that require antibiotics, even when treated by the same doctor, according to research published ...
Pediatrics Mar 18, 2013 | 3 / 5 (2) | 0
The U.S. Food and Drug Administration (FDA) this month expanded the options for patients with chronic myeloid leukemia and one form of acute lymphoblastic leukemia that carries the Philadelphia chromosome (Ph+ALL). It approved ...
Cancer Dec 21, 2012 | not rated yet | 0
(HealthDay)—Iclusig (ponatinib) has been approved by the U.S. Food and Drug Administration to treat two rare forms of leukemia..
Cancer Dec 16, 2012 | not rated yet | 0
(AP)—The Supreme Court will decide whether generic drug manufacturers can be held responsible in state courts for possible design defects that are in the brand-name medicine they are copying.
Medications Nov 30, 2012 | not rated yet | 0
Huntsman Cancer Institute (HCI) researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard ...
Cancer Nov 30, 2012 | not rated yet | 0
(HealthDay) -- Marqibo (vincristine sulfate liposome injection) has been approved by the U.S. Food and Drug Administration to treat adults with a rare form of blood and bone marrow cancer, Philadelphia chromosome negative ...
Cancer Aug 10, 2012 | not rated yet | 0
(HealthDay) -- Marqibo (vincristine sulfate liposome injection) has been approved by the U.S. Food and Drug Administration to treat adults with Philadelphia chromosome negative acute lymphoblastic leukemia ...
Medications Aug 10, 2012 | not rated yet | 0
Researchers at Thomas Jefferson University Hospital in Philadelphia and a multicenter team of investigators have found that carotid artery stenting (CAS) is safe and effective in patients age 70 and older.
Cardiology Mar 26, 2012 | 4 / 5 (1) | 0
About one in five or six cases of adult leukaemia in Western populations relates to so-called chronic myeloid leukaemia, or CML. Treatment of CML usually relies on inhibitors of the abnormal protein that causes the condition ...
Cancer Jan 30, 2012 | not rated yet | 0
A pair of studies by The Children's Hospital of Philadelphia (CHOP) and State Farm® identify factors that may lead teens to drive with multiple peer passengers and, then, how those passengers may affect their driver's ...
Health Jan 24, 2012 | not rated yet | 0
(HealthDay)—The anti-cancer drug Gleevec (imatinib) has received new U.S. Food and Drug Administration approval to treat the most common type of pediatric cancer, affecting some 2,900 children each year, the agency said ...
Cancer Jan 25, 2013 | not rated yet | 0